2002
October 11, 2017
|By natasa
- A pharmacovigilance department was set up to monitor drug safety.
- Remedica successfully underwent a routine GMP inspection by UNICEF.
By submitting this form, you consent to the processing of your personal data for the purpose of communicating with you the latest news, newsletter, information, and events related to Remedica (referred to as the “Purpose”).
You also hereby declare that you are an adult, able to give his/her consent freely.
Personal information collected includes your full name and email address and the information shall be forwarded and will be used by Remedica’s Marketing department only, and, only for the Purpose.
The information included in this form shall be retained in an electronic list for as long as you consent. Should at any time you wish to withdraw your consent and unsubscribe, you can do so by writing to the Marketing department via email to the address [email protected] and then the information retained in the electronic list shall be deleted within ten (10) working days from the date of your e-mail, and, you will be notified accordingly.
Remedica Ltd is the controller of your personal data. Should you have any concerns, you may contact our Data Protection Officer ([email protected]), Remedica Ltd in Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus, and Tel. 35725553000
You have a right to lodge a complaint to the Office of the Commissioner for the Protection of Personal Data by contacting them at +35722818456.